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Subjective tinnitus is the perception of sound in the absence of external or
bodily-generated sounds. Chronic tinnitus is a highly prevalent condition affecting over
70 million people in Europe. A wide variety of comorbidities, including hearing loss,
psychiatric disorders, neurodegenerative disorders, and temporomandibular joint (TMJ)
dysfunction, have been suggested to contribute to the onset or progression of tinnitus;
however, the precise molecular mechanisms of tinnitus are not well understood and
the contribution of genetic and epigenetic factors remains unknown. Human genetic
studies could enable the identification of novel molecular therapeutic targets, possibly
leading to the development of novel pharmaceutical therapeutics. In this article, we briefly
discuss the available evidence for a role of genetics in tinnitus and consider potential
hurdles in designing genetic studies for tinnitus. Since multiple diseases have tinnitus
as a symptom and the supporting genetic evidence is sparse, we propose various
strategies to investigate the genetic underpinnings of tinnitus, first by showing evidence
of heritability using concordance studies in twins, and second by improving patient
selection according to phenotype and/or etiology in order to control potential biases
and optimize genetic data output. The increased knowledge resulting from this endeavor
could ultimately improve the drug development process and lead to the preventive or
curative treatment of tinnitus.
Keywords: epidemiology, genetic, hearing loss, tinnitus, meniere’s disease, phenotyping, subtype
INTRODUCTION
Tinnitus, the perception of a phantom sound, affects nearly 15% of the population. It can
severely affect quality of life in 3–6% of the population, becoming chronically bothersome, and
incapacitating (Davis and Refaie, 2000). From the social perspective, tinnitus leads to a loss
of productivity and increases the risk of receiving a disability pension (Friberg et al., 2012).
Lopez-Escamez et al. Molecular Epidemiology of Tinnitus
Tinnitus varies on the perceptional level, ranging from beeping,
hissing, ringing, and buzzing to drumming sounds. Tinnitus
can be objective (generated by the ear and perceived by
external people) or subjective (only perceived by the concerned
individual), pulsatile (synchronous or asynchronous), constant
or intermittent, loud or faint, perceived in one or both ears,
or within the head. Despite the fact that noise overexposure
is most frequently associated with tinnitus (15%) (Nicolas-Puel
et al., 2006), tinnitus may be associated with many conditions
other than dysfunction of the auditory system (e.g., obesity,
diabetes, smoking, alcohol consumption, neck pain, allergies,
thyroid dysfunction, brain tumors, temporomandibular joint
(TMJ) dysfunction and as a side effect of several medications)
(Baguley et al., 2013). Tinnitus often coincides with severe
psychological dysfunction. Anxiety, depression, and disruptions
in the execution of cognitive and attention tasks are frequently
reported. Another symptom commonly associated with tinnitus
is a decreased tolerance to loud sounds (hyperacusis), which is
observed in 40–55% of patients with tinnitus (Baguley, 2003;
Schecklmann et al., 2014). Tinnitus can be categorized based on
psychoacoustic features and the levels of severity, psychological
distress, and daily life disability. According to its duration,
tinnitus is often assessed as follows: up to 3 months of duration
is considered “acute” between 3 and 12 months “subacute” and
more than 1 year is considered “chronic.” At present, there
are no effective drugs for tinnitus while the need for effective
treatments is likely to increase (Cederroth et al., 2013). The
lack of treatment success in clinical trials has been attributed to
the heterogeneity of clinical conditions associated with tinnitus.
Genetic studies would help in identifying diagnostic markers for
subgroups of tinnitus patients (subtypes) or markers of resistance
to treatment in order to improve the selection of subjects and
optimize treatment outcome. In addition, since the current
pipeline of drugs to treat tinnitus is rather small (Cederroth et al.,
2013), genetic studies could provide additional targets for drug
development.
In this article, we briefly present the current evidence
regarding heritability in tinnitus, the hypothetical
pathophysiological mechanisms of tinnitus and the underlying
challenges of tinnitus phenotyping. We next propose different
approaches toward the genetic elucidation of tinnitus including
the analysis of concordance in twins, familial aggregation
studies, exome sequencing in families with multiple cases,
and sequencing studies in cohorts of patients with extreme
phenotypes. We suggest that tinnitus subtyping strategies
based on precise definition of phenotypes would favor
the selection of homogeneous groups of tinnitus patients
with matching controls that might serve as a solid basis for
genetic studies.
GENETIC CONTRIBUTION TO TINNITUS:
THE MISSING EVIDENCE
There is a lot of evidence to support a genetic contribution for
complex disorders: differences in the prevalence according to the
ethnic background, familial aggregation, and higher concordance
in monozygotic twins than in dizygotic twins. In this section, we
address each of these in the context of tinnitus.
The prevalence of tinnitus ranges from 6 to 30%, while the
prevalence of severe tinnitus ranges from 0.7 to 16% in the same
studies (Cooper, 1994; Sindhusake et al., 2003; Hasson et al., 2010;
Krog et al., 2010; Michikawa et al., 2010; Nondahl et al., 2010;
Shargorodsky et al., 2010; Engdahl et al., 2012; McCormack et al.,
2014; Park et al., 2014; Gallus et al., 2015). This wide range likely
reflects the large number of questions that have been used to
define tinnitus, which makes the genetic basis of tinnitus difficult
to determine. An age-dependent increase in the prevalence of
tinnitus is seen across all studies, with a peak in the seventh
decade of life (Gopinath et al., 2010; Shargorodsky et al., 2010;
Park et al., 2014). There is no agreement on whether there is a
gender bias, but there is a tendency for males to be more affected
than women (Cooper, 1994; Sindhusake et al., 2003; Hasson et al.,
2010; Krog et al., 2010; Michikawa et al., 2010; Nondahl et al.,
2010; Shargorodsky et al., 2010; Engdahl et al., 2012; McCormack
et al., 2014; Park et al., 2014; Gallus et al., 2015).
With regard to ethnic differences, studies performed in Egypt
(Khedr et al., 2010), Japan (Michikawa et al., 2010), and Nigeria
(Lasisi et al., 2010) suggest that the prevalence is broadly the
same. However, one study reported a higher prevalence of
tinnitus in non-Hispanic whites than in other racial or ethnic
groups in the U.S. (Shargorodsky et al., 2010). Additional ethnic
studies are needed to infer potential genetic influences on
tinnitus.
Table 1 presents a summary of human genetic studies for
tinnitus. Most of them were genotyping studies with a small
sample size (54–288) on candidate genes including KCNE1,
KCNE3, GDNF, BDNF, COCH, and SLC12A (Sand et al., 2010,
2011, 2012a,b; Gallant et al., 2013). Overall, no associations
were found with one exception (Pawelczyk et al., 2012). The
small sample size and the paucity of patient characterization
(tinnitus only being characterized as chronic) could account for
these outcomes. For instance, the study by Sand et al. (2010)
included 201 German patients with “chronic tinnitus” and no
controls. The authors used public genotyping data from other
studies as control subjects, without any ancestry-informative
markers to prevent population stratification. Pawelczyk et al.
(2012) conducted a case-control study in Poland including 626
subjects exposed to occupational noise (128 with tinnitus and
498 without tinnitus). While they reported an association with
the SNP rs915539 in normal hearing subjects (p = 0.005),
no ancestry-informative markers were used and the current
standards in genetic association studies require a replication
in another association study with an independent population,
something that to our knowledge has not been yet reported.
Studies on familial tinnitus are scarce. A large study analyzed
the occurrence of familial tinnitus within 198 European families
(Hendrickx et al., 2007). The authors found a familial correlation
between siblings reaching 0.16, and the finding was independent
of differences in age, gender, and hearing threshold. Using a
Cox proportional model, the risk of developing tinnitus was
estimated to be 1.7 times higher in siblings with tinnitus than
that observed in families without tinnitus, after correcting for risk
factors (Hendrickx et al., 2007). However, the authors reasoned
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TABLE 1 | Available human genetic studies on tinnitus.
Tinnitus property HL Size of the
population
Reported gene Design Associations References
Tinnitus associated
with NIHL
Occupational Noise N = 626 (128 with
tinnitus)
KCNE1, SLC12A2 Genotyping KCNE1 associated with
tinnitus independent of HL
Pawelczyk et al., 2012
Chronic Controlled N = 240 GDNF, BDNF Genotyping None Sand et al., 2012b
Chronic Controlled N = 95 KCTD12 Genotyping None Sand et al., 2012a
Chronic Not reported N = 201 KCNE1 Genotyping None Sand et al., 2010
Unknown All N = 54 SLC6A4 Genotyping None Deniz et al., 2010
Chronic Not reported N = 288 KCNE3 Sanger sequencing None Sand et al., 2011
Tinnitus associated
with HFHL
HFHL N = 1 family COCH Linkage analysis Single family study Gallant et al., 2013
Unknown All N = 28,066 None Familial aggregation Population-based study Kvestad et al., 2010
Unknown Not reported N = 198 families None Familial aggregation Multiple family study Hendrickx et al., 2007
HL, Hearing loss.
that this could be simply due to the fact of raising awareness
on tinnitus within the family. The selection of multicase families
with tinnitus for exome sequencing studies to search for rare
variants with a high penetrant effect has not been explored.
To the best of our knowledge, there is no published work
on the concordance, or heritability of tinnitus from twin
studies. Such studies could appropriately address the issue of
sibling influences on awareness and provide solid evidence on
whether or not there is a genetic contribution to tinnitus.
Heritability is an estimation of the genetic contribution in
relation to the phenotypic variability for a particular trait that
occurs within populations. The variation in the phenotype for
a particular trait in a population arises from differences in the
genotype and environmental variation. Falconer’s formula for
estimating heritability is based on the concordance rates among
monozygotic and dizygotic twins:
h2 = 2∗(rMZ− rDZ) (1)
where h2 is the heritability or the proportion of variance due
to genetic factors and r is the correlation coefficient between
MZ and DZ twins. Heritability values have a theoretical range
of 0–1.5. In general, it is considered that a trait has a genetic
component if h2 is between 0.5 and 1. With this approach in
mind, we have initiated a study to evaluate the concordance of
tinnitus in twins and ongoing data collection is in support of a
genetic contribution to some forms of tinnitus.
TINNITUS PHENOTYPING: NEEDLE IN A
HAYSTACK?
A major limitation in genetic association studies, whatever
the field of research, is the classification of subjects according
to a common phenotype. Tinnitus is considered a symptom.
It is thought that the large number of clinical conditions
associated with chronic tinnitus has contributed to the
unsuccessful clinical trials and genetic studies listed above.
An initial suggestion of classification into subgroups was
proposed by the Tinnitus Research Initiative in 2010 (Landgrebe
et al., 2010) followed by the Tinnitus Holistic Simplified
Classification (Cianfrone et al., 2015). The Tinnitus Holistic
Simplified Classification proposes that tinnitus stems from
(i) auditory alterations (Auditory Tinnitus), (ii) complex
auditory-somatosensory interactions (Somatosensory Tinnitus),
(iii) psychopathological-auditory interactions (Psychopathology-
related Tinnitus), and (iv) 2 or all of the previous mechanisms
(Combined Tinnitus). Others have classified tinnitus into
originating either from the auditory system (usually peripheral,
rarely central) or from the somatosensory system (head and
neck), or a combination of the two (Levine and Oron, 2015).
Recently, another work has revealed that somatic tinnitus may
represent a subtype (Ward et al., 2015), being more prevalent in
younger groups, unrelated to hearing loss but rather associated
with TMJ disorders. Overall, the definition of tinnitus subtypes is
still a matter of debate, and no consensus has been found due
to the large number of contributing factors, the multitude of
etiologies, and the psychoacoustic profiles of tinnitus.
The benefits of subtyping approaches in genetic studies
have been shown in a genome-wide association study (GWAS)
for major depressive disorders (MDD). The analysis of more
than 9000 cases did not yield robustly replicated genetic loci,
and it was thought that the heterogeneity contributed to the
reduction in the power of the genetic associations. The selection
of a severe subtype of MDD with accompanying melancholia
allowed the successful mapping of a single gene, namely
SIRT1 (CONVERGE, 2015). Such stratification of diseases into
homogeneous subcategories or subtypes has been successful in
reducing genetic background noise and clinical heterogeneity,
ultimately helping in the identification of genetic variants
(Gelernter et al., 2006; Schwartz et al., 2010). Although these
approaches may lead to hits that are not applicable to the general
population, they may still facilitate (i) the understanding of
the mechanisms of specific subcategories of tinnitus, (ii) the
development of biological markers of tinnitus subtypes, and (iii)
the identification of candidates for drug development.
How can the tinnitus field benefit from genetic studies to
improve treatment outcome? While such conceptual approaches
are at the forefront of disease treatment, an example can be
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provided with ongoing research on a specific subtype of Autism
SpectrumDisorder (ASD), namely Phelan-McDermid syndrome,
which is a rare disorder with deletions or mutations in the
SHANK3 gene. Studies have shown the beneficial use of IGF-1
for neuronal function using cells with the SHANK3 mutations
(Bozdagi et al., 2013). This approach has been tested on nine
children in a pilot study showing the successful therapeutic
effects of IGF-1 treatment in improving social behavior and
reducing repetitive behavior (Kolevzon et al., 2014), whose
positive outcomes have also been reported in a preclinical mouse
model of autism (Bozdagi et al., 2013). Such studies show how
genetic studies, coupled with preclinical research, can help in
developing targeted treatments for different disease subtypes.
Such examples are on rare monogenic disorders, so how can
this be applied to tinnitus, which—assuming there is significant
heritability—would likely be polygenic? Tinnitus is probably
a polygenic condition, however genomic research will reveal
whether some subtypes of familial tinnitus, are monogenetically
driven.
Several disorders have been categorized into subgroups
in order to facilitate the identification of biomarkers and
optimize treatment outcomes. Schizophrenia is segregated into
subtypes according to the expression of behavioral symptoms
(e.g., paranoid, disorganized, catatonic, undifferentiated, and
residual). Multiple sclerosis (MS) subtypes, on the other
hand, are defined on the basis of time-course development
(primary progressive, relapsing-progressive, relapsing-remitting,
secondary progressive, transitional progressive), prognosis, and
pathogenicity (obtained through the analysis of biopsies) (Bitsch
and Brück, 2002). Interestingly, in the case of MS, studies
have revealed blood, CSF, and MRI biomarkers associated
with particular subgroups. Alzheimers disease is categorized
into three subgroups thanks to metabolic profiling (Bredesen,
2015): inflammatory (presence of specific blood markers),
noninflammatory (absence of these blood markers), and cortical
(no specific Alzheimer gene detected, but normally associated
with zinc deficiency). The value of these biomarkers in clinical
practice remains to be established due to the large phenotypic
variability.
The above examples possess numerous advantages over
tinnitus. First, these are diseases whereas tinnitus is considered
a symptom. Second, they rely on available biomarkers from
blood, CSF, molecular, and histological profiles. An example of
the advantage that these biomarkers provide to the refinement
of genetic studies has been shown in bipolar disorders. Bipolar
disorders are classified into two major subtypes. Kynurenic acid
(KYNA) has been recently identified as a CSF biomarker in
both subtypes, and has been associated with a greater history
of psychosis. This biomarker provided a powerful advantage
in a recent GWAS study involving only 76 patients and 46
controls that identified a single nucleotide polymorphism causing
a reduction of sorting nexin 7 (SNX7) expression in astrocytes,
leading to higher IL-1β production, and subsequently increasing
KYNA in patients carrying this variant (Sellgren et al., 2015).
The tinnitus field suffers from a lack of such biomarkers.
Current subtyping strategies thus rely on the clinical features of
tinnitus (acute vs. chronic, objective vs. subjective, pulsatile
vs. nonpulsatile, constant vs. intermittent), taking into
account cofactors such as hearing loss, vertigo, headache,
psychiatric influences, and somatosensory origins, as well
as its triggers (e.g., noise trauma, accident, medication,
Ménière’s disease). A putative list of factors that need to be
taken into account is shown in Table 2. Which of these are
relevant to tinnitus will only emerge in future clinical and
genetic studies.
The selection of individuals for genetic studies will
have to consider all the above features, including severity,
duration, gender, age, age of onset, pitch, intensity, hearing
thresholds, psychological burden, and etiology, to reduce clinical
heterogeneity, and to control biases. Categorizing tinnitus
subtypes according to tinnitus pitch, severity, and hearing profile
might be sufficient, however this needs to be tested. In addition,
tinnitus perception may change over time and patients might
be classified into a different subtype, or even belong to multiple
subtypes (e.g., noise trauma causing unilateral deafness, being
initially acute, and then transiting to chronic stages, becoming
bilateral with the emergence of psychiatric burden but still
unilaterally dominant, and pitch decreasing with age). As a
consequence, psychoacoustic evaluations should be performed
in the first years of the onset of tinnitus to reduce the number of
confounding factors. Finally, there is little biological information
on the mechanisms underlying each of these subtypes, and
this is where genetics may play an important role by defining
a subgroup of tinnitus subjects with a defined phenotype. The
identification of tinnitus subtypes is thus in the early stages.
TABLE 2 | List of potential factors to take into account in genetic studies
on tinnitus.
Forms of tinnitus
Subjective, objective
Pulsatile, nonpulsatile
Constant, intermittent
Unilateral, bilateral
Temporal
Acute, subacute, chronic
Severity
Moderate, severe, catastrophic
Etiology
Noise trauma, medication, post-traumatic stress disorder, Ménière’s disease, TMJ
Influencers
Age, sex, ethnicity
Cofactors
Hearing loss, hyperacusis, vertigo, headache, psychiatric (stress, anxiety,
depression), somatosensory
Comorbidities
Hypertension, diabetes, cancer, chronic pain, neurological problems,
Response to treatment
Improvement, worsening, none
We propose a nonexhaustive list of factors to take into account when designing
genetic studies on tinnitus. A large variety of tinnitus subtypes may thus emerge from
the combination of severity, forms of tinnitus, etiology, temporal characteristics, and
comorbidities.
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PATHOPHYSIOLOGY OF TINNITUS
Mechanisms Mediating Tinnitus Perception
A detailed phenotyping of tinnitus patients is necessary to
investigate the genetic and environmental factors contributing to
its development. Both auditory and psychological components
of tinnitus are important aspects to be evaluated. Studies reveal
that tinnitus possesses a dual mechanism that emerges most
frequently from (i) peripheral dysfunctions leading to changes in
(ii) the activity of the central auditory pathway likely influenced
by nonauditory networks that feed tinnitus-related distress
and possibly influence its persistence (Figure 1). The current
knowledge stipulates that the perception of tinnitus resembles the
phantom perception of an amputated limb, whereby the loss of
sensory input leads to compensation mechanisms in the brain
(hyperactivity). Indeed, tinnitus networks are similar to those
involved in chronic pain (perception, salience, distress, memory),
and could contribute to the maintenance of tinnitus, in the
absence of the initial trigger (Langguth et al., 2013). Confirming
the idea about the loss of peripheral (cochlear) input causing
tinnitus, human subjects that wore a silicone earplug for 7 days
experienced tinnitus (Schaette et al., 2012), which disappeared
after the earplug was removed, supporting the hypothesis that
therapeutic interventions restoring cochlear output to the brain
can abolish phantom perception.
The relationship between peripheral damage and tinnitus has
been recently reviewed (Schaette, 2014). Patients with conductive
hearing loss (e.g., otosclerosis) often complain about tinnitus,
which is then completely abolished after surgery (Gersdorff et al.,
2000; Ayache et al., 2003; Sobrinho et al., 2004). Similarly, hearing
aids, and cochlear implants are capable of improving tinnitus in
50% of patients, and abolishing tinnitus in 20% of cases (Moffat
et al., 2009; Olze et al., 2012; Schaette, 2014). Mertens et al.
provided the only long-term study that clearly shows a reduction
in tinnitus and hypercusis with cochlear implants (Mertens
et al., 2016). Interestingly, one study reported lower amplitudes
of wave I recorded from click auditory brainstem responses
(ABRs) in tinnitus patients with normal hearing thresholds when
measured by pure tone audiometry, suggesting the existence of
cochlear damage leading to a decreased input toward the brain
(Schaette and McAlpine, 2011). Overall, these studies suggest
a peripheral (cochlear) contribution in some forms of tinnitus,
which supports the inclusion of ABR measurements in patients
with normal audiometry. Central mechanisms that compensate
for the lack of input (homeoplastic plasticity) could emerge.
Interestingly, fMRI studies revealed that people with tinnitus
have increased activity in auditory, and nonauditory networks
such as the limbic system, including the nucleus accumbens
(Rauschecker et al., 2010; Leaver et al., 2011). It was suggested
that this increased activity was a result of reduced functional
output of the ventromedial prefrontal cortex in tinnitus patients
(Leaver et al., 2011). Activation of the nucleus accumbens
would lead to increased inhibition of thalamic reticular nucleus
neurons, and thus result in increased inhibition of medial
FIGURE 1 | Hypothetical schema of tinnitus pathogenesis. (A) Noise exposure in animal models leads to deafferentation between inner hair cells and afferent
neurons, or hair cell loss subsequently causing a reduction in the spontaneous activity of the auditory nerve (AN). In contrast, an increase in the spontaneous firing
rates is observed along the auditory pathway [dorsal cochlear nucleus (CN), inferior colliculus (IC) and auditory cortex (A1)]. Tonotopic organization (TO) is also altered
in the auditory cortex (B,C). Neuroimaging studies in humans with tinnitus identified the involvement of nonauditory areas such as the salience network [the anterior
cingulate cortex (ACC) and the insula (INS)], as well as the emotional components of tinnitus involving an increased connectivity between the amygdala (AMY), and the
primary auditory cortex (A1). SFR, spontaneous firing rate; NS, neuronal synchrony. This figure was modified from Elgoyhen et al. (2015) with permission from the
Nature Publishing Group (Elgoyhen et al., 2015).
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geniculate body neurons. In patients with gaze-induced tinnitus,
hypometabolic theta activity, and reduced inhibition in the
auditory cortex were found to occur hand in hand with reduced
medial geniculate body activity (van Gendt et al., 2012). However,
the precision of EEGmeasures in tinnitus assessment has recently
been questioned (Pierzycki et al., 2016). It can be concluded that
there is clear evidence of a profound impact of the “emotional
brain network” on the generation of manifestation of tinnitus.
Mechanisms Mediating Tinnitus-Related
Distress
Most people have probably transiently experienced tinnitus
at some point in their life. However, in some cases tinnitus
becomes permanent and can seriously impact the quality
of life. Interestingly, in individuals with chronic persistent,
nonfluctuating tinnitus, the psychoacoustic characteristics of
tinnitus (e.g., loudness or pitch) are not unequivocally related
to its severity or the treatment outcome (Jastreboff and Hazell,
1993). In chronic tinnitus, the interpretation of the tinnitus
percept might be more important in impacting the severity of
complaints than the sound itself (Jastreboff and Hazell, 1993;
Henry and Meikle, 2000; Andersson, 2003; Hiller and Goebel,
2007). Psychological distress, which includes negative attitudes,
and cognitions, impaired concentration, insomnia, depression,
and anxiety, is a significant predictor for the variability in the
quality of life (Erlandsson and Hallberg, 2000). Accumulating
evidence suggests that cognitive misinterpretations, negative
emotional reactivity and attention processes are crucial in
dysfunctional habituation leading to severe tinnitus distress
(Erlandsson and Hallberg, 2000; Kröner-Herwig et al., 2003;
Zachriat and Kröner-Herwig, 2004; Cima et al., 2012).
The emotional neural networks that possibly influence the
peripheral to central circuit in tinnitus patients likely comprise
the regions known to be involved in normal emotional behavior.
These regions can be altered in mood disorders and involve the
medial prefrontal cortex, the medial, and caudolateral orbital
cortex (medial prefrontal network), anterior cingulate, amygdala,
hippocampus, and ventromedial parts of the basal ganglia
(Jastreboff, 1990; Drevets et al., 2008). Indeed, clinical imaging of
individuals with tinnitus provides evidence that tinnitus-related
and distress-related brain networks overlap, such as the limbic,
and paralimbic regions (Rauschecker et al., 2010), the amygdala
(Shulman, 1995; Mirz et al., 2000), the hippocampus (Lockwood
et al., 1998; Landgrebe et al., 2009), the basal ganglia (Lowry
et al., 2004; Cheung and Larson, 2010) and the subcallosal region,
including the nucleus accumbens (Mühlau et al., 2006; Leaver
et al., 2011). Favoring the possible cross-modal interactions of
the limbic system central responsiveness, perhaps related to
the peripheral damage after auditory trauma, thalamic/amygdala
projections change their activity pattern during tinnitus (Knipper
et al., 2013). Overall, it appears to be important to measure
emotional components during tinnitus phenotyping.
TINNITUS PHENOTYPING STRATEGIES
Precise phenotyping of patients with tinnitus is the first step
in defining clusters of patients based on a few variables that
will configure a tinnitus subtype (Tyler et al., 2008). Poor
phenotyping can significantly contaminate large epidemiological
or genetic studies leading to a loss of power and false-positive
results. For instance, not controlling for emotional factors (such
as stress, anxiety, or depression) could lead to the identification
of genes falsely associated with tinnitus, while they would be
truly linked to depression. Hearing profile and tinnitus pitch
are minimum requirements, but additional measures—including
questionnaires covering psychological aspects—are also needed.
The common psychological comorbidities of depression, anxiety,
insomnia and cognitive impairment disable 10–50% of patients
suffering from tinnitus. Similarly to some tinnitus measures,
assessment of tinnitus comorbidities has been neglected in drug
development efforts. This gap is currently being addressed in a
consensus-driven effort to provide international guidelines on
Core OutcomeMeasures in Tinnitus (COMiT) (Hall et al., 2015),
which will define the domains and related instruments necessary
to perform tinnitus studies.
An example that illustrates the importance of genetic studies
in subtypes of tinnitus patients is the identification of a
polymorphism in the serotonin transporter gene (SLC6A4),
which has been previously shown to be associated with anxiety
(Lesch et al., 1996), and is now linked with the severity of the
psychological conditions associated with tinnitus (Deniz et al.,
2010). As a consequence of these findings, one could envisage that
SLC6A4 variants could become markers of tinnitus distress, and
that serotonin reuptake inhibitors could be targeted at subtypes
of patients with tinnitus and depression in the presence of the risk
allele. However, some of the mechanisms and drug treatments of
these tinnitus comorbidities might differ from patients without
tinnitus, which would suggest tinnitus-specific mechanisms.
Defining potential tinnitus subtypes will be essential in
investigating the heritability for each subtype in familial and twin
studies. This strategy will enhance the results in genetic studies,
in addition to improving clinical trial outcomes. However,
this can be a challenging task since a subtype will also be
characterized by either a successful therapeutic intervention or
by the identification of a gene associated with, for example,
a particular form of tinnitus. In the context of genetics, this
conundrum can be potentially addressed with concordance
studies in twins by identifying traits that are more prevalent in
monozygotic twins than in dizygotic twins.
The assessment of a patient with tinnitus should include
a complete audiological evaluation, psychoacoustic measures
of tinnitus and several instruments to determine the severity
of tinnitus, and its impact on health-related quality of life.
However, it is important to note that the exclusion of
measures could also lead to the inclusion of nonspecific
groups and bias the genetic analysis or treatment outcome. A
comprehensive measure of tinnitus features is thus required to
characterize each form of tinnitus. To achieve this important
classification procedure, considerable thought should be invested
in selecting the right tools for measuring tinnitus experience (e.g.,
validated questionnaires, psychoacoustic measures, audiological
measures), and the selection will depend on the aims of the study.
A number of instruments have been recommended by
the Tinnitus Research Initiative (Langguth et al., 2007) for
the assessment of treatment outcomes in clinical trials. Of
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note, we emphasize that conventional pure tone audiometry
(PTA), which measures hearing thresholds from 250 Hz to
8 kHz, is no longer adapted to tinnitus cases. A number
of tinnitus patients diagnosed with no hearing loss when
measured with conventional audiometry tend to be diagnosed
with somatosensory tinnitus. However, high-frequency PTA (up
to 20 kHz) might reveal an auditory component to tinnitus,
thereby completely reallocating a patient into another subtype
category. Normal hearing should be considered from <20 dB
HL up to 16 kHz in adults. Interestingly, one study reported
lower amplitudes of wave I (based on I/V ratio) recorded
from click auditory brainstem responses (ABRs) in tinnitus
patients with normal hearing thresholds, however the latter
were measured with PTA only up to 12 kHz, suggesting that a
decreased cochlear input toward the brain causes some forms
of tinnitus (Schaette and McAlpine, 2011). ABRs could thus
become important in revealing cochlear damage and objectively
categorize subjects into a specific peripherally injured tinnitus
subtype. However, since ABRs are known to be sensitive at higher
frequencies (Don and Eggermont, 1978; Eggermont and Don,
1980), differences in hearing thresholds above 12 kHz could
have accounted for these wave I/V differences in amplitude in
the tinnitus group. This reinforces the importance of assessing
PTA up to at least 16 kHz. Distortion products of otoacoustic
emissions (DPOAEs) are measures of outer hair cell function.
Often neglected in the assessment of tinnitus patients, DPOAEs
can measure both a decreased function and a loss of outer
hair cells (OHCs) likely due to cell death, or a gain in OHC
function as can sometimes be observed in subgroups of tinnitus
patients with hyperacusis (Sztuka et al., 2010). Psychoacoustic
measures have been most commonly used to determine the
pitch-matched frequency and intensity of the perceived tinnitus.
Little is known on how tinnitus pitch can evolve with time
and whether patients with different pitches might constitute
different subtypes. Neuroimaging studies have been recently
reviewed (Elgoyhen et al., 2015) and it has been proposed that
tinnitus heterogeneity is the consequence of abnormal activity
from specific networks. Neuroimaging techniques, including
fMRI, EEG, and MEG, could thus constitute an important
set of instruments to help categorize tinnitus patients into
different subgroups according to the involvement of specific
networks (such as the hippocampal-cortical memory networks,
the frontoparietal control system, the salience network, and the
autonomic nervous system). Research is currently underway
to define which networks specify a given subtype of tinnitus
and how relevant these tools can be for characterizing
tinnitus.
DESIGNING HUMAN GENETIC STUDIES
Over the last three decades, medical genetic research has focused
largely on inherited variation in the human genome. Most of the
DNA variability can be explained by single nucleotide variants
(SNVs) and small structural variants involving one or a few
nucleotides (insertions, deletions), or large structural variants
involving hundreds to thousands of nucleotides (copy number
variants, CNVs). These variants mostly occur in noncoding
regions, which can affect the degree of expression of a given allele,
but CNVs may also involve coding regions causing partial or
complete loss or gain of function.
There are several complementary approaches to demonstrate
an association between genetic variants and tinnitus in
humans:
• focusing on patients with a common genetic background (e.g.,
identical twins or familial aggregation studies) to estimate
heritability.
• designing case-control studies (e.g., cases with common
etiology or disease such as Ménière’s disease) to search for rare
variants on monogenic tinnitus families.
• GWAS using large cohorts of sporadic patients to search for
common regulatory variants.
All of these designs can be used to identify the most heritable
tinnitus phenotype and to find candidate genes. However, the
complexity and heterogeneity of tinnitus implies the need for
in-depth tinnitus phenotyping, using questionnaires as well as
audiological and psychoacoustic measures, to accurately identify
genes responsible for tinnitus resilience, or susceptibility.
Methods: Genotyping vs. Sequencing
There are two methods for reading the genome: genotyping and
sequencing. Genotyping determines the differences in SNVs in
a given individual when their sequence is compared with the
reference genome. Sequencing is the process of determining
the nucleotide order of a given DNA fragment and is usually
performed for short fragments of DNA by the chain termination
method developed by Sanger et al. (1977). New sequencing
technologies such as pyrosequencing have enabled rapid, large-
scale sequencing of human genome, including whole genome
sequencing (WGS) and the most popular enrichment approach
for coding regions, whole exome sequencing (WES) (Mardis,
2008).
Genotyping larger cohorts of patients with a given disorder
using microarrays has been the basis for GWAS during the
last 15 years. Trait-associated SNVs have identified regulatory
common genetic variants (minor allele frequency—MAF > 0.05)
with small genetic effects, but are unlikely to define the causative
rare variants in most cases. Although GWAS for complex
disorders have resulted in great progress, most of the candidate
genes investigated in case-control studies, including candidate
genes for chronic tinnitus, could not be replicated. Replication
is essential for establishing the credibility of a genotype—
phenotype association, whether derived from candidate genes
or GWAS (Mardis, 2008). Large-scale genotyping studies are
based on the knowledge that SNVs along the entire genome are
conserved in specific regions, and SNVs can be used as markers
of the sequence in these regions. To generate a map of SNVs
in the human genome, the HapMap Project was carried out
(International HapMap, 2003). GWAS have identified common
SNVs in large-population studies, mostly in noncoding regions
with unknown functional significance (Cooper and Shendure,
2011). Furthermore, this design is not suitable for the study of
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genetic conditions that are caused by rare or novel mutations
(Robinson et al., 2011).
On the other hand, high-throughput sequencing technologies,
such as WES, are designed to enrich the sequencing of
coding regions, which contain 85% of disease-causing mutations
defining rare variants in familial and sporadic patients in 65%
of cases (Samuels et al., 2013). Moreover, the cost of WGS or
WES studies has been dramatically reduced in recent years,
facilitating their implementation for clinical diagnosis (Biesecker
and Green, 2014). Although genotyping has been the preferred
approach to identify common SNVs with regulatory effects in
GWAS, the decreased cost involved in WGS is predicted to lead
to genotyping being replaced in a few years. WES and WGS
have become the standard in searching for rare variants in any
genomic study.
Candidate Gene vs. Genomic Approaches
Several genes have been considered as candidate genes for
tinnitus, but replication studies, are missing or have failed to
confirm previously reported associations (Table 1). The main
reason for the lack of reproducibility is population stratification
or the systematic ancestry differences between cases and controls,
which is a confounder in genetic association studies (Price
et al., 2010). Instead, targeted sequencing of candidate genes is
considered a suitable method to determine the relevance of a
candidate variant previously identified by a genomic approach.
Genotyping microarrays and next-generation sequencing
technologies help to overcome the limitations of traditional
approaches. Either WGS or WES combined with linkage studies
have become the most efficient strategies for discovering causal
genes for Mendelian diseases (Zhang, 2014). We have used this
approach to identify novel and rare variants in FAM136A and
DTNA genes in autosomal dominant familial Ménière’s disease
(Requena et al., 2015). We were also able to reveal a missense
variant in the PRKCB gene in a family with Ménière’s disease
segregating low-frequency sensorineural hearing loss (Martín-
Sierra et al., 2016). The next step will be to investigate rare
variants of candidate genes in more families and sporadic
cases. This approach can be used for specific forms of familial
tinnitus after obtaining a detailed phenotype. To the best of
our knowledge, this strategy has not been applied yet to specific
tinnitus subtypes. The clinical heterogeneity of tinnitusmakes the
selection of patients according to the tinnitus phenotype a crucial
step in the design of the study.
Sample Selection
There are compelling reasons to focus on tinnitus symptoms
that are defined by a common trigger or clinical syndrome.
First, the more homogenous the tinnitus phenotype, according
to the tinnitus pitch and hearing profile, the better the
chance that an allelic variant segregates with the particular
phenotype. The reason to classify tinnitus by its frequency is
the tonotopic gradient of gene expression in the mammalian
cochlea (Yoshimura et al., 2014). The frequency selectivity is
maintained along the auditory pathway and precise regulation of
this gene expression is required to preserve tonotopy. Individuals
with selective low- or high-frequency sensorineural hearing loss
could potentially be good candidates for a case-control study.
The reduction in error will increase the power to detect a small
gene effect. Second, patients with different tinnitus conditions
will vary in other ways that increase the variance and reduce the
power to detect gene effects. For instance, a completely different
set of factors may mediate the onset of chronic tinnitus due
to age-related hearing loss vs. an ear injury or a cardiovascular
disorder. For this reason, the selection of younger individuals is
preferred, since the cumulative effect of different epigenetic and
environmental triggers may favor the onset of tinnitus in elderly
individuals. Third, completely different measures are needed
to adequately characterize a tinnitus phenotype in different
conditions, for example, in noise-induced tinnitus vs. stress-
induced tinnitus.
There are several limitations when designing genetic studies
in patients with chronic tinnitus. First, the clinical heterogeneity
observed makes it difficult to select patients with the same
phenotype (Sand et al., 2007). A clinically well-defined phenotype
is a prerequisite in designing a case-control study. Since most
patients with tinnitus also have a certain degree of hearing loss
and a number of comorbidities related to tinnitus, the design
should control these biases by selecting individuals with the same
hearing profile and tinnitus pitch. Since it has been hypothesized
that tinnitus subjects will possibly accumulate multiple common
and rare variants segregating with the phenotype, it could be
advantageous to select younger individuals in multicase families
in order to search for highly penetrant rare variants with a large
effect size (Requena et al., 2014). In contrast, older subjects with
tinnitus will probably reflect the cumulative effect of epigenetic
and environmental factors throughout their lives, diluting the
effect of genetic variation. Therefore, a possible solution is
to reduce the selection to a subset of patients with extreme
phenotypes, filtering them according to early age of onset, gender,
ethnic background, and for instance, specific clinical features
that would show higher concordance in monozygotic twins. Such
strategies have proven successful in previous studies, whereby the
exclusion of hearing impairment increases the number of twins
concordant for noise sensitivity (Heinonen-Guzejev et al., 2005)
and the selection of a subtype of severe melancholia increases the
concordance of major depressive disorder (CONVERGE, 2015).
Furthermore, the selection of a reference population matching
for age, gender, ethnicity, comorbidities, emotional burden, and
quality of life could also be critical, since many confounder
factors may arise.
A second limitation for small-size case-control studies is that
tinnitus is a highly prevalent condition, which anticipates that
many genetic variants could confer resilience or susceptibility
(Veltman and Brunner, 2012). A large genetic heterogeneity is
expected for chronic tinnitus, which would possibly complicate
the functional interpretation of rare variants in genes encoding,
for instance, proteins that are known to have a physiological
role in the synapse. Often associated with tinnitus is the high-
frequency SNHL that is typically observed in presbycusis and is
known to have a significant genetic heterogeneity (Fransen et al.,
2015).
Learning from previous research in fields such as pain
and schizophrenia, which are very heterogeneous disorders, we
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believe that studies should be restricted to themost homogeneous
groups in terms of etiology, age, gender balance, severity of
tinnitus, audiometric profile, and comorbidities. Moreover, the
smaller the variation of the genetic background within a group,
the more robust the study will be. In this direction, we favor
the following sequence of prioritization: studying twins >
multiplex families with tinnitus > Ménière’s disease patients
with chronic tinnitus, groups with cisplatin-induced tinnitus
following chemotherapy, noise overexposure (military training
or work exposure), or ARHL (age-related hearing loss) > large
health cohorts with undefined etiology.
Design of Tinnitus Sequencing Studies
Let’s consider one example for which the initiating trigger is well-
defined (i.e., noise trauma or Ménière’s disease), and another
example where the initiating trigger is not clearly defined. After
sensorineural hearing loss, some patients experience short-term
tinnitus, but do not develop chronic tinnitus, suggesting some
type of resilience. However, a few patients with some intrinsic
susceptibility will experience chronic persistent tinnitus.
In a case-control design, the case group is defined as having
chronic persistent tinnitus as a consequence of the trigger, and
controls must have had the initiating trigger as well, leading to
temporary tinnitus, or no tinnitus. Data collected from cases
and controls can include previous tinnitus history, history of
psychiatric disorders, assessment of traits, exposure to stressors,
and actual comorbid conditions relevant to tinnitus domains
(hearing loss, hyperacusis, stress, anxiety, or depression). Then,
cases and controls are compared at the level of individual
domain-specific measures. Measures from different domains can
also be compared (e.g., hearing loss and stress) in order to better
understand the subgroups. Such comprehensive studies will
accelerate the gathered knowledge on the interaction between
causative factors and the genetic components underlying a
specific tinnitus phenotype.
Obviously, the method chosen for the case-control studies
will depend on the incidence, prevalence of the condition and
the proportion of those with the phenotype of interest that seek
care. Direct ascertainment in the population might differ from
the phenotypes assessed in tinnitus clinics (self-selected samples)
since the psychiatric conditions and behaviors of those who seek
care can be genetically influenced. As an example, treatment
resistance, and psychiatric comorbidities are more likely to occur
in patients with migraines that get treated by a specialist than
in a population-based sample for the same disorder (Lipton
et al., 2003; Kolodner et al., 2004; Bigal et al., 2006). In addition,
identifying appropriate controls for the tinnitus groups from
specialty care centers can be particularly challenging.
Epigenetic Factors Possibly Contributing
to Tinnitus
Epigenetics is the discipline that studies changes to the genome
that do not involve modifications in the DNA sequence per se
(Cederroth et al., 2007). Since psychological distress is often
associated with tinnitus, and psychosocial stress has been well
documented in animals and people as a modifier of epigenetic
marks (Franklin et al., 2012; Bohacek and Mansuy, 2015;
Vaiserman, 2015), it is tempting to speculate that tinnitus
could also emerge from epigenetic modifications. The two
main epigenetic mechanisms are gene methylation and histone
modifications. DNA methylation typically reduces or even
silences the expression of genes encoded by methylated DNA.
The modification of histones may either enhance or reduce
gene expression, depending on the type of histone and type
of modification. Histones, which are structural proteins of
chromatin, are responsible for tight packaging of DNA, and
their modifications (e.g., acetylation or deacetylation) affect
the accessibility of DNA by various enzymes. Changes in
methylation occur during embryonic development as early as
a few hours in the paternal genome after fertilization, whereas
in the maternal genome this is a more passive phenomenon.
After the implantation of the embryo, along the differentiation of
embryonic tissues, cells become more abundantly methylated—
a phenomenon called reprogramming (Jaenisch, 1997; Mayer
et al., 2000). In adulthood, the environment can induce
changes in specific cell types. Monozygotic twins offer an
excellent illustration of this phenomenon, since despite their
genetic identity, there are morphological variations and also
different susceptibility to diseases. Environmental factors such
as psychosocial stress, smoking, physical activity, or diet can
contribute to such epigenetic drifts.
In animal models, restraint stress, acute forced swim stress,
social isolation stress, and many other types of stress can
induce epigenetic modifications, such as on the loci of the
glucocorticosteroid receptor (GR) or brain-derived neurotropic
factor (BDNF) (Fuchikami et al., 2010; Stankiewicz et al., 2013).
There are many studies showing that experimentally induced
behavioral changes are linked to these epigenetic modifications;
this was also observed in people suffering from depression or
anxiety (Bagot et al., 2014).
To date, no published studies have focused on possible
epigenetic aspects of tinnitus onset or progression. However,
some studies have indirectly approached this topic in the context
of hearing loss (Provenzano and Domann, 2007; Wolber et al.,
2014). For instance, the pattern of gene methylation in a group
of patients with age-related hearing impairment was found to
differ from that found in well-hearing subjects (Wolber et al.,
2014). Because the incidence of hearing loss in tinnitus patients
is high, it would be tempting to speculate that at least some of
the epigenetic targets may overlap between the two conditions
(Goldman and Holme, 2010; Mazurek et al., 2010). In addition,
the comorbidity of psychological conditions such as anxiety or
stress (Hébert and Lupien, 2007; Hébert et al., 2012) may possibly
create a disease-specific pattern of epigenetic modifications.
The epigenetic modifications often affect specific tissues,
but not the entire organism, which renders the study of
human auditory tissues challenging (e.g., inner ear and central
auditory pathway) due to their limited access. However,
epigenetic modifications could occur during fetal development
(e.g., maternal stress during gestation)—a phenomenon called
“fetal reprogramming” (Moisiadis and Matthews, 2014). Then,
peripheral tissues might be used as a proxy for brain-specific
alterations (Stenz et al., 2015). Finally, if they occur during
adulthood, the consequences of the insults can also be found
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across generations both at the level of the phenotype and in the
male germline epigenome (Anway et al., 2005; Franklin et al.,
2010). These possibilities offer new routes for investigating the
relationship between tinnitus and epigenetic changes related to
comorbid conditions such as stress, anxiety, and depression.
CONCLUSIONS
Human genetic studies in tinnitus are at the very beginning.
Accordingly, concordance studies in twins are an essential first
step in defining the heritability of tinnitus. In a second step, the
precise selection of subjects based on careful phenotyping will
facilitate the identification of genes involved in the resilience
or susceptibility to developing tinnitus or tinnitus-related
comorbidities. The molecular characterization of tinnitus will
not only lead to a better understanding of the pathways and
networks regulating the onset of disease, but also shed light on
the physiological processes involved, leading to the development
of new pharmacological treatments.
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